Related Experiment Video
Updated: Aug 22, 2026

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections
Published on: May 8, 2017
Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis
Michael W Konstan1, Steven M Butler, Mary Ellen B Wohl
1Department of Pediatrics, Rainbow Babies and Children's Hospital and Case Western Reserve University School of Medicine, Cleveland, Ohio, USA. mwk3@cwru.edu
Insights
Early growth and nutrition are strongly linked to better lung function in children with cystic fibrosis (CF). Maintaining adequate weight-for-age from age 3 to 6 is crucial for long-term pulmonary health.
Area of Science:
- Pediatric Pulmonology
- Pediatric Nutrition
- Cystic Fibrosis Research
Background:
- Cystic Fibrosis (CF) affects lung function and nutritional status in children.
- Early growth and nutritional status are potential indicators of long-term health outcomes in CF patients.
Purpose of the Study:
- To investigate the relationship between growth, nutritional status, and pulmonary function in young children with CF.
- To assess how early indicators of lung disease and nutritional status predict later pulmonary function.
Main Methods:
- A cohort of 931 children with CF was studied.
- Weight-for-age (WFA), height-for-age (HFA), and percent ideal body weight (%IBW) at age 3 were correlated with pulmonary function at age 6.
- Changes in WFA from age 3 to 6 were analyzed for their association with pulmonary function at age 6.
Main Results:
- Nutritional indicators (WFA, HFA, %IBW) at age 3 showed weak association with lung disease signs at age 3 but strong association with pulmonary function at age 6.
- Children with WFA below the 5th percentile at age 3 had significantly lower pulmonary function (FEV1) at age 6 compared to those above the 75th percentile.
- Sustained adequate WFA (above 10th percentile) from age 3 to 6 correlated with the highest pulmonary function at age 6.
- Presence of lung disease signs at age 3 was associated with reduced pulmonary function at age 6.
Conclusions:
- Growth and nutritional status are critical determinants of pulmonary function in children with CF.
- Early interventions targeting growth, nutrition, and lung disease in young CF patients may positively impact long-term pulmonary outcomes.
Objective:
To determine the relation of growth and nutritional status to pulmonary function in young children with cystic fibrosis (CF).
Study Design:
The relation of weight-for-age (WFA), height-for-age (HFA), percent ideal body weight (%IBW), and signs of lung disease at age 3 years with pulmonary function at age 6 years was assessed in 931 patients with CF. Associations of changes in WFA from age 3 to 6 on pulmonary function were also assessed.
Results:
WFA, HFA, and %IBW were poorly associated with lung disease at age 3 years, but all were strongly associated with pulmonary function at age 6 years. Those with WFA below the 5th percentile at age 3 had lower pulmonary function at age 6 compared with those above the 75th percentile (FEV(1): 86 +/- 20 [SD] versus 102 +/- 18 % predicted, respectively). Pulmonary function was highest in those whose WFA remained >10th percentile from age 3 to 6 (FEV(1): 100 +/- 19 % predicted) and lowest in those who remained <10th percentile (84 +/- 21 % predicted). Patients with signs and symptoms of lung disease at age 3 years had lower pulmonary function at age 6 years.
Conclusions:
Aggressive intervention early in life aimed at growth and nutrition and/or lung disease may affect pulmonary function.
More Related Videos
07:38Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome
Published on: August 3, 2021
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...